Related Experiment Video
Updated: Aug 3, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Electronic Dashboard to Improve Outcomes in Pediatric Patients With Type 1 Diabetes Mellitus
Lily Sandblom1, Chirag Kapadia2, Vinay Vaidya2
1University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
Insights
An electronic dashboard improved outcomes for pediatric patients with type 1 diabetes mellitus (T1DM). This tool enhanced patient education, appointment compliance, and follow-up care, leading to better glycemic control and fewer hospital admissions.
Area of Science:
- Pediatric Endocrinology
- Digital Health Interventions
- Chronic Disease Management
Background:
- Increasing incidence of type 1 diabetes mellitus (T1DM) in children.
- Challenges in achieving optimal glycemic control in pediatric T1DM.
- Potential of electronic health data for improving patient outcomes.
Purpose of the Study:
- To evaluate the impact of an electronic dashboard on pediatric T1DM patient outcomes.
- To assess if data-driven population-based interventions improve diabetes management.
- To test the hypothesis that electronic dashboard monitoring enhances T1DM care.
Main Methods:
- Retrospective analysis of pediatric T1DM patients at Phoenix Children's Hospital.
- Utilized an electronic dashboard to collect patient data.
- Analyzed diabetes management activities and patient outcomes including A1C, admissions, and follow-up care.
Main Results:
- Increased patient education from 48% to 80%.
- Improved appointment compliance and timely post-hospitalization follow-up.
- Median A1C levels decreased from 9.1% to 8.2%; hospital admissions and ED visits reduced by 20%.
Conclusions:
- Implementation of an electronic dashboard significantly improved outcomes for pediatric T1DM patients.
- The electronic dashboard serves as a valuable tool for enhancing care in T1DM and other chronic pediatric conditions.
- This data-driven approach can be adopted by other institutions to improve pediatric chronic disease management.
Background And Objectives:
Incidence of type 1 diabetes mellitus (T1DM) is increasing, and these patients often have poor glycemic control. Electronic dashboards summating patient data have been shown to improve patient outcomes in other conditions. In addition, educating patients on T1DM has shown to improve glycated hemoglobin (A1C) levels. We hypothesized that using data from the electronic dashboard to monitor defined diabetes management activities to implement population-based interventions would improve patient outcomes.
Methods:
Inclusion criteria included patients aged 0 to 18 years at Phoenix Children's Hospital with T1DM. Patient data were collected via the electronic dashboard, and both diabetes management activities (A1C, patient admissions, and visits to the emergency department) and patient outcomes (patient education, appointment compliance, follow-up after hospital admission) were analyzed.
Results:
This study revealed that following implementation of the electronic dashboard, the percentage of patients receiving appropriate education increased from 48% to 80% (Z-score = 23.55, P < .0001), the percentage of patients attending the appropriate number of appointments increased from 50% to 68.2%, and the percentage of patients receiving follow-up care within 40 days after a hospital admission increased from 43% to 70%. The median A1C level decreased from 9.1% to 8.2% (Z-score = -6.74, P < .0001), and patient admissions and visits to the emergency department decreased by 20%.
Conclusions:
This study shows, with the implementation of an electronic dashboard, we were able to improve outcomes for our pediatric patients with T1DM. This tool can be used at other institutions to improve care and outcomes for pediatric patients with T1DM and other chronic conditions.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

